Literature DB >> 9162436

The crosstalk between insulin and the sympathetic nervous system: possible implications in the pathogenesis of essential hypertension.

G Lembo1, C Vecchione, G Iaccarino, B Trimarco.   

Abstract

Patients with non-insulin dependent diabetes mellitus and obesity show an elevated risk for development of arterial hypertension, while many non-obese, non-diabetic patients with essential hypertension display resistance to insulin-induced glucose disposal, accompanied by hyperinsulinaemia. This close association has lead some investigators to postulate that insulin resistance could be implicated in the pathogenesis of essential hypertension. Among the various factors considered as potential links between insulin resistance and high blood pressure, the sympathetic nervous system can be considered a prime candidate. In particular, our recent data in hypertensive patients have documented that the muscle sympathetic response evoked by insulin is about threefold greater than that observed in normal subjects. Such finding is well in agreement with previous observations in hypertensives obtained with experimental maneuvers and extends them by showing an abnormal sympathetic response to a physiological stimulus like insulin, so important in every day life. Recent data both from our and other laboratories have clearly established that an acute activation of sympathetic nervous system is able to antagonize insulin-mediated glucose uptake in the skeletal muscle, making very real the possibility that a primary defect in insulin sensitivity in hypertension may be further aggravated by the greater sympathetic response evoked by episodic stimuli, such as postprandial hyperinsulinaemia. However, while insulin evokes an increase in sympathetic nervous activity, at same time it is able to blunt the vasoconstrictive effects caused by the reflex sympathetic activation. Such vascular modulating effect of insulin is lost in essential hypertension, indicating that the resistance to insulin effect in this disease is not only present in skeletal muscle metabolism but it is also evident at the vascular level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9162436

Source DB:  PubMed          Journal:  Blood Press Suppl        ISSN: 0803-8023


  8 in total

Review 1.  Epidemiology of risk factors for hypertension: implications for prevention and therapy.

Authors:  M Kornitzer; M Dramaix; G De Backer
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

2.  Temporal Relationship Between Childhood Body Mass Index and Insulin and Its Impact on Adult Hypertension: The Bogalusa Heart Study.

Authors:  Tao Zhang; Huijie Zhang; Ying Li; Dianjianyi Sun; Shengxu Li; Camilo Fernandez; Lu Qi; Emily Harville; Lydia Bazzano; Jiang He; Fuzhong Xue; Wei Chen
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

3.  Sympathetic nerve hyperactivity in non-diabetic offspring of patients with type 2 diabetes mellitus.

Authors:  R J Huggett; A J Hogarth; A F Mackintosh; D A S G Mary
Journal:  Diabetologia       Date:  2006-09-13       Impact factor: 10.122

Review 4.  Obesity, hypertension, and sympathetic nervous system activity.

Authors:  D B Corry; M L Tuck
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

Review 5.  Role of the Autonomic Nervous System in the Hemodynamic Response to Hyperinsulinemia-Implications for Obesity and Insulin Resistance.

Authors:  Jacqueline K Limberg; Rogerio N Soares; Jaume Padilla
Journal:  Curr Diab Rep       Date:  2022-03-05       Impact factor: 4.810

6.  Angiogenesis in the New Zealand obese mouse model fed with high fat diet.

Authors:  Adriana Balwierz; Anna Polus; Urszula Razny; Lukasz Wator; Grzegorz Dyduch; Romana Tomaszewska; Stephan Scherneck; Hans Joost; Aldona Dembinska-Kiec
Journal:  Lipids Health Dis       Date:  2009-04-06       Impact factor: 3.876

7.  Association of Serum Calcium and Insulin Resistance With Hypertension Risk: A Prospective Population-Based Study.

Authors:  Xiaoyan Wu; Tianshu Han; Jian Gao; Yunlong Zhang; Shengnan Zhao; Rongbo Sun; Changhao Sun; Yucun Niu; Ying Li
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501

Review 8.  Hypertension in the metabolic syndrome and diabetes: pathogenesis, clinical studies, and treatment.

Authors:  Joseph L Izzo
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Nov-Dec       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.